E-LIB Suche - Ergebnisse für: Herishanu Y

1

Additional booster doses in patients with chronic lymphocyt..:

Campanella, A. ; Capasso, A. ; Heltai, S....
American Journal of Hematology. 99 (2024) 4 - p. 745-750 , 2024

Link: https://doi.org/10.1002/..

2

An open‐label phase 1/2 study of favezelimab plus pembroliz..:

Lavie, D. ; Johnson, N. ; Borchmann, P....
Hematological Oncology. 41 (2023) S2 - p. 364-366 , 2023

Link: https://doi.org/10.1002/..

3

P1086: FAVEZELIMAB (ANTI–LAG-3) AND PEMBROLIZUMAB CO-BLOCKA..:

Gregory, G. ; Timmerman, J. ; Lavie, D....
HemaSphere. 6 (2022) - p. 976-977 , 2022

Link: https://doi.org/10.1097/..

4

P666: ACALABRUTINIB ± OBINUTUZUMAB VS OBINUTUZUMAB + CHLORA..:

Sharman, J. P. ; Egyed, M. ; Jurczak, W....
HemaSphere. 6 (2022) - p. 564-565 , 2022

Link: https://doi.org/10.1097/..

5

Novel agents for the treatment of lymphomas during pregnanc..:

Luttwak, E. ; Gurevich-Shapiro, A. ; Azem, F....
Blood Reviews. 49 (2021) - p. 100831 , 2021

Link: https://doi.org/10.1016/..

6

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients ..:

Perry, C. ; Luttwak, E. ; Balaban, R....
Blood Advances. 5 (2021) 16 - p. 3053-3061 , 2021

Link: https://doi.org/10.1182/..

7

Interim PET-CT–guided therapy in elderly patients with Hodg..:

Bentur, O. S. ; Dann, E. J. ; Paran, E....
Annals of Hematology. 98 (2019) 7 - p. 1665-1674 , 2019

Link: https://doi.org/10.1007/..

8

Replacing carmustine by thiotepa and cyclophosphamide for a..:

Joffe, E ; Rosenberg, D ; Rozovski, U...
Bone Marrow Transplantation. 53 (2017) 1 - p. 29-33 , 2017

Link: https://doi.org/10.1038/..

9

Outcome predictors in elderly Hodgkin's lymphoma patients p..:

Avivi, I. ; Paran, E. ; Bentur, O....
Hematological Oncology. 35 (2017) S2 - p. 309-310 , 2017

Link: https://doi.org/10.1002/..

10

MALT1 INHIBITION USING THE SMALL MOLECULE INHIBITOR MI‐2 EF..:

Herishanu, Y. ; Dezorella, N. ; Shapiro, M...
Hematological Oncology. 35 (2017) S2 - p. 400-400 , 2017

Link: https://doi.org/10.1002/..

11

CD84 mediates CLL-microenvironment interactions:

Marom, A ; Barak, A F ; Kramer, M P...
Oncogene. 36 (2016) 5 - p. 628-638 , 2016

Link: https://doi.org/10.1038/..

12

105 HIGH RESPONSE RATE FOR AZACITIDINE-LENALIDOMIDE (VI-LEN..:

Mittelman, M. ; Filanovsky, K. ; Ofran, Y....
Leukemia Research. 39 (2015) - p. S54 , 2015

Link: https://doi.org/10.1016/..

13

P-287 Infectious events are much more prevalent following a..:

Ofran, Y. ; Filanovsky, K. ; Gafter-Gvili, A....
Leukemia Research. 37 (2013) - p. S151-S152 , 2013

Link: https://doi.org/10.1016/..

14

Treatment of acute ischemic stroke in patients with cerebra..:

Benbassat, J. ; Baumal, R. ; Herishanu, Y.
QJM. 104 (2010) 1 - p. 73-82 , 2010

Link: https://doi.org/10.1093/..

15

HEPARANASE MODULATES HEPARINOIDS ANTICOAGULANT ACTIVITIES V..:

Katz, B. ; Muhl, L. ; Zwang, E....
Journal of Thrombosis and Haemostasis. 5 (2007) - p. P-W-287-P-W-287 , 2007

Link: https://doi.org/10.1111/..